About
Acousia Therapeutics develops novel small molecule drug candidates to enhance and preserve natural hearing in patients with sensorineural hearing loss, aiming to treat and prevent various forms of hearing loss including age-related and drug-induced hearing loss.
Explore Acousia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.